BIOMILQ
Unlocking human potential with breakthrough mammary biotechnology.
- Company typePrivate
- Founded2020
- HeadquartersDurham, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What BIOMILQ does
BIOMILQ is a women-owned and science-led start-up building a mammary biomanufacturing platform to produce bioauthentic human milk ingredients for better human health. By combining the unique capabilities of human mammary cells with a scalable biomanufacturing process, BIOMILQ aims to demonstrate the power of our platform through impact in early-life nutrition with ingredients that promote immune, gut, and neurological development.
BIOMILQ firmographics
Firmographics- Name
- BIOMILQ
- Legal name
- BIOMILQ, INC.,
- Website
- https://www.biomilq.com/
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Unlocking human potential with breakthrough mammary biotechnology.
- Ownership category
- akta.pro rank
Where BIOMILQ is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BIOMILQ business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Infrastructure
Revenue model
- Human mammary cell-derived milk product: BIOMILQ is developing a human mammary cell-derived milk product as an infant feeding alternative, targeting the infant formula market with a breastmilk-like product that has a lower environmental footprint.
Go-to-market motion1 record
BIOMILQ product offering
Product offeringCore offering
BIOMILQ is developing a cell-cultured human milk product using human mammary cells to replicate the milk production conditions found inside the human body. The product is intended to serve as a breastmilk-like infant feeding alternative with a lower environmental footprint than conventional infant formula. The company is currently in the development and regulatory navigation phase and has not yet launched a commercial product.
Product overview
BIOMILQ is a biotechnology company developing a single core product: cell-cultured human milk derived from human mammary cells. The company replicates milk production conditions found inside the human body to create a breastmilk-like infant feeding alternative. The company is currently in development stage with no commercial product launched yet, working toward market entry within approximately four years while navigating regulatory pathways.
Differentiator
Problem solved
Functional benefit
Products and services
- Cell-Cultured Human Milk
Quantifiable outcome
- Lower environmental footprint compared to conventional infant formula
Companies that use BIOMILQ
Customer profileSegments1 record
Ideal customer profiles1 record
BIOMILQ technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
BIOMILQ partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
BIOMILQ competitors and assessment
Company assessmentMarket position
Weaknesses5 records
Competitive moat5 records
Customer concentration
BIOMILQ social profiles
Digital presenceBIOMILQ financial estimates
Financial estimateRevenue estimate
Valuation estimate
BIOMILQ leadership team
Management profileNumber of profiles
Profiles2 records
BIOMILQ funding detail
Funding detailFunding overview
Funding rounds3 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BIOMILQ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BIOMILQ
What does BIOMILQ do?
BIOMILQ is developing a cell-cultured human milk product using human mammary cells to replicate the milk production conditions found inside the human body. The product is intended to serve as a breastmilk-like infant feeding alternative with a lower environmental footprint than conventional infant formula. The company is currently in the development and regulatory navigation phase and has not yet launched a commercial product.
Is BIOMILQ a public or private company?
BIOMILQ is a private company. It is classified as venture growth investor backed and is currently operating.
When was BIOMILQ founded?
BIOMILQ was founded in 2020. It employs 11 to 50 people.
Where is BIOMILQ based?
BIOMILQ is headquartered in Durham, United States, in the North America region.
How does BIOMILQ make money?
One revenue line is on record: human mammary cell-derived milk product.
Does BIOMILQ have an API?
No public API is recorded for BIOMILQ.